
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 13.53 | 1.74111106822 | 777.09 | 825 | 777 | 3139169 | 810.3769269 | CS |
4 | 32.23 | 4.24979232321 | 758.39 | 825 | 709 | 3327543 | 757.12882042 | CS |
12 | -78.13 | -8.99338129496 | 868.75 | 902.4999 | 677.0912 | 4089580 | 776.49783519 | CS |
26 | 14.22 | 1.8315301391 | 776.4 | 935.625 | 677.0912 | 3854870 | 798.64724435 | CS |
52 | -88.83 | -10.1006310762 | 879.45 | 972.53 | 677.0912 | 3643372 | 826.28126487 | CS |
156 | 499.87 | 171.92433362 | 290.75 | 972.53 | 289.62 | 3198680 | 619.30781414 | CS |
260 | 627.55 | 384.83473355 | 163.07 | 972.53 | 129.21 | 3240428 | 452.03786137 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관